Tethys, Duke Establish Type 2 Diabetes Registry | GenomeWeb

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Tethys Bioscience today announced that it and the Duke Clinical Research Institute have established the Prevail patient registry to analyze primary care ambulatory practices for risk factor management of patients in the US who have a high risk of converting to type 2 diabetes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.